

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.36872306 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.36872306 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.11159296 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.11159296 |
| 5 | desmosome organization (GO:0002934) | 5.83753253 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.60304494 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50526988 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 5.42543888 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.13513311 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.05553292 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.98941627 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.98941627 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.98941627 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.98490216 |
| 15 | complement activation, alternative pathway (GO:0006957) | 4.89594474 |
| 16 | establishment of skin barrier (GO:0061436) | 4.87584388 |
| 17 | urea cycle (GO:0000050) | 4.86943418 |
| 18 | urea metabolic process (GO:0019627) | 4.86943418 |
| 19 | tryptophan metabolic process (GO:0006568) | 4.80853050 |
| 20 | coenzyme catabolic process (GO:0009109) | 4.78249893 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.72731802 |
| 22 | protein carboxylation (GO:0018214) | 4.66825501 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.66825501 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.60115006 |
| 25 | regulation of water loss via skin (GO:0033561) | 4.59226833 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.55578289 |
| 27 | cellular modified amino acid catabolic process (GO:0042219) | 4.54283934 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.52617906 |
| 29 | regulation of protein activation cascade (GO:2000257) | 4.52121195 |
| 30 | cysteine metabolic process (GO:0006534) | 4.51657972 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.51213308 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.45493238 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.43318142 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36542504 |
| 35 | hemidesmosome assembly (GO:0031581) | 4.35861980 |
| 36 | bile acid metabolic process (GO:0008206) | 4.29963976 |
| 37 | regulation of complement activation (GO:0030449) | 4.28048457 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 4.27493740 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.26109077 |
| 40 | keratinization (GO:0031424) | 4.21694964 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.19564514 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.17182990 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.15107234 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.14063814 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.14063814 |
| 46 | phospholipid efflux (GO:0033700) | 4.11246996 |
| 47 | multicellular organismal water homeostasis (GO:0050891) | 4.09035990 |
| 48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.06197714 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.02677044 |
| 50 | lysine metabolic process (GO:0006553) | 4.02204151 |
| 51 | lysine catabolic process (GO:0006554) | 4.02204151 |
| 52 | epoxygenase P450 pathway (GO:0019373) | 4.01652020 |
| 53 | regulation of cholesterol homeostasis (GO:2000188) | 3.99889134 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 3.94730252 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.94533732 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 3.94533732 |
| 57 | macromolecular complex remodeling (GO:0034367) | 3.94533732 |
| 58 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.85953877 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 3.81992833 |
| 60 | regulation of cholesterol esterification (GO:0010872) | 3.81811621 |
| 61 | positive regulation of lipid catabolic process (GO:0050996) | 3.81183433 |
| 62 | sodium ion export (GO:0071436) | 3.80233048 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 3.80137275 |
| 64 | negative regulation of sterol transport (GO:0032372) | 3.80137275 |
| 65 | cofactor catabolic process (GO:0051187) | 3.71345241 |
| 66 | drug catabolic process (GO:0042737) | 3.64323357 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.64116778 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.61211613 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.60788854 |
| 70 | cellular potassium ion homeostasis (GO:0030007) | 3.57564043 |
| 71 | glutamate metabolic process (GO:0006536) | 3.55104104 |
| 72 | intestinal cholesterol absorption (GO:0030299) | 3.53879152 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 3.53553815 |
| 74 | ethanol oxidation (GO:0006069) | 3.53476951 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 3.53413928 |
| 76 | cholesterol efflux (GO:0033344) | 3.53393532 |
| 77 | water homeostasis (GO:0030104) | 3.52149836 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50277174 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46367780 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46367780 |
| 81 | phospholipid homeostasis (GO:0055091) | 3.44502923 |
| 82 | keratinocyte proliferation (GO:0043616) | 3.44306094 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.42902198 |
| 84 | cellular glucuronidation (GO:0052695) | 3.41851622 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.41623540 |
| 86 | fibrinolysis (GO:0042730) | 3.40776272 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.38464191 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.38122393 |
| 89 | organic acid catabolic process (GO:0016054) | 3.38122393 |
| 90 | drug metabolic process (GO:0017144) | 3.37067464 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.36718950 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.36526490 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 3.34179459 |
| 94 | ketone body metabolic process (GO:1902224) | 3.33815132 |
| 95 | biotin metabolic process (GO:0006768) | 3.33785329 |
| 96 | linoleic acid metabolic process (GO:0043651) | 3.32841494 |
| 97 | valine metabolic process (GO:0006573) | 3.32777423 |
| 98 | hormone catabolic process (GO:0042447) | 3.32342111 |
| 99 | arginine metabolic process (GO:0006525) | 3.31643952 |
| 100 | primary alcohol catabolic process (GO:0034310) | 3.31520405 |
| 101 | sterol homeostasis (GO:0055092) | 3.31117505 |
| 102 | glycine metabolic process (GO:0006544) | 3.30854952 |
| 103 | cell communication involved in cardiac conduction (GO:0086065) | 3.30513039 |
| 104 | fatty acid oxidation (GO:0019395) | 3.28718587 |
| 105 | amine catabolic process (GO:0009310) | 3.27629574 |
| 106 | cellular biogenic amine catabolic process (GO:0042402) | 3.27629574 |
| 107 | exogenous drug catabolic process (GO:0042738) | 3.27133654 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.26616139 |
| 109 | benzene-containing compound metabolic process (GO:0042537) | 3.26211702 |
| 110 | plasma lipoprotein particle assembly (GO:0034377) | 3.25369891 |
| 111 | lipid oxidation (GO:0034440) | 3.23316456 |
| 112 | low-density lipoprotein particle clearance (GO:0034383) | 3.23227366 |
| 113 | complement activation (GO:0006956) | 3.22326934 |
| 114 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.20847068 |
| 115 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.03790635 |
| 116 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.96278319 |
| 117 | skeletal muscle adaptation (GO:0043501) | 2.95384893 |
| 118 | myelin maintenance (GO:0043217) | 2.93986330 |
| 119 | macroautophagy (GO:0016236) | 2.89362076 |
| 120 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.85263783 |
| 121 | peptide cross-linking (GO:0018149) | 2.83317430 |
| 122 | one-carbon compound transport (GO:0019755) | 2.79556705 |
| 123 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.74747048 |
| 124 | intermediate filament organization (GO:0045109) | 2.72514819 |
| 125 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.71378966 |
| 126 | cell communication by electrical coupling (GO:0010644) | 2.71276534 |
| 127 | cell-substrate junction assembly (GO:0007044) | 2.68886644 |
| 128 | molting cycle (GO:0042303) | 2.68343530 |
| 129 | hair cycle (GO:0042633) | 2.68343530 |
| 130 | potassium ion homeostasis (GO:0055075) | 2.68324995 |
| 131 | sexual reproduction (GO:0019953) | 2.67032766 |
| 132 | creatine metabolic process (GO:0006600) | 2.60061914 |
| 133 | neuronal ion channel clustering (GO:0045161) | 2.58336582 |
| 134 | central nervous system myelination (GO:0022010) | 2.54824839 |
| 135 | axon ensheathment in central nervous system (GO:0032291) | 2.54824839 |
| 136 | epidermis development (GO:0008544) | 2.52951102 |
| 137 | glomerular basement membrane development (GO:0032836) | 2.51175105 |
| 138 | keratinocyte differentiation (GO:0030216) | 2.51084025 |
| 139 | regulation of p38MAPK cascade (GO:1900744) | 2.50534165 |
| 140 | cellular sodium ion homeostasis (GO:0006883) | 2.48653450 |
| 141 | cardiac muscle contraction (GO:0060048) | 2.48033555 |
| 142 | plasma membrane repair (GO:0001778) | 2.47753191 |
| 143 | cell volume homeostasis (GO:0006884) | 2.44942174 |
| 144 | cardiac conduction (GO:0061337) | 2.43223540 |
| 145 | muscle filament sliding (GO:0030049) | 2.41015690 |
| 146 | actin-myosin filament sliding (GO:0033275) | 2.41015690 |
| 147 | negative regulation of protein localization to cell surface (GO:2000009) | 2.39888571 |
| 148 | apical protein localization (GO:0045176) | 2.37910862 |
| 149 | regulation of cell communication by electrical coupling (GO:0010649) | 2.37483501 |
| 150 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.33969283 |
| 151 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.33796003 |
| 152 | regulation of actin filament-based movement (GO:1903115) | 2.32693750 |
| 153 | negative regulation of inclusion body assembly (GO:0090084) | 2.32065765 |
| 154 | regulation of protein localization to cell surface (GO:2000008) | 2.31843203 |
| 155 | potassium ion import (GO:0010107) | 2.31746894 |
| 156 | sodium ion homeostasis (GO:0055078) | 2.31600964 |
| 157 | chemical homeostasis within a tissue (GO:0048875) | 2.29999760 |
| 158 | NADH metabolic process (GO:0006734) | 2.29932354 |
| 159 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.29165713 |
| 160 | endothelial cell chemotaxis (GO:0035767) | 2.28559813 |
| 161 | peripheral nervous system axon ensheathment (GO:0032292) | 2.27494700 |
| 162 | myelination in peripheral nervous system (GO:0022011) | 2.27494700 |
| 163 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.25363595 |
| 164 | striated muscle contraction (GO:0006941) | 2.25320940 |
| 165 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.24916526 |
| 166 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.24880739 |
| 167 | cardiac muscle cell action potential (GO:0086001) | 2.23722381 |
| 168 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23421362 |
| 169 | carnitine transmembrane transport (GO:1902603) | 2.23149849 |
| 170 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.23020019 |
| 171 | relaxation of cardiac muscle (GO:0055119) | 2.22887614 |
| 172 | ethanol metabolic process (GO:0006067) | 2.22708513 |
| 173 | glutamate secretion (GO:0014047) | 2.22194024 |
| 174 | import into cell (GO:0098657) | 2.21717839 |
| 175 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.19967465 |
| 176 | iron ion import (GO:0097286) | 2.19321569 |
| 177 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.18793339 |
| 178 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.18559835 |
| 179 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.17685509 |
| 180 | gap junction assembly (GO:0016264) | 2.16009380 |
| 181 | carnitine transport (GO:0015879) | 2.15804802 |
| 182 | amino-acid betaine transport (GO:0015838) | 2.15804802 |
| 183 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.15126304 |
| 184 | metanephric nephron epithelium development (GO:0072243) | 2.14485481 |
| 185 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.14403434 |
| 186 | myofibril assembly (GO:0030239) | 2.14262891 |
| 187 | diterpenoid biosynthetic process (GO:0016102) | 2.14179963 |
| 188 | carnitine metabolic process (GO:0009437) | 2.13141051 |
| 189 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.12006036 |
| 190 | surfactant homeostasis (GO:0043129) | 2.11865962 |
| 191 | carnitine shuttle (GO:0006853) | 2.11852017 |
| 192 | cerebellar granule cell differentiation (GO:0021707) | 2.11725778 |
| 193 | striated muscle hypertrophy (GO:0014897) | 2.11262773 |
| 194 | sarcomere organization (GO:0045214) | 2.09061254 |
| 195 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.08297788 |
| 196 | epidermal cell differentiation (GO:0009913) | 2.07204963 |
| 197 | metanephric nephron tubule development (GO:0072234) | 2.07166090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.78306236 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48734183 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.68878577 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.29911935 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.87935954 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.82192945 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.48156676 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66321020 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.21303364 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.67237149 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.49681506 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.39626815 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80702816 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71331926 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64875044 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63691276 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58832545 |
| 18 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.56764259 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53856117 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53099731 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50805811 |
| 22 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45605782 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45451429 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44321017 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44148295 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41323267 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40490440 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39691786 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38099293 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36800723 |
| 31 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32282246 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.32161659 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29325210 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29192748 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28360435 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25518611 |
| 37 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25383434 |
| 38 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.24609188 |
| 39 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.24609188 |
| 40 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.24609188 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24306816 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22639867 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21071041 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21028932 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20877008 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.18586480 |
| 47 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17757552 |
| 48 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16848719 |
| 49 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16307512 |
| 50 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14783081 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14679021 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14170835 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14170835 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12840676 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12840676 |
| 56 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11264257 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11196998 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10697953 |
| 59 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09988327 |
| 60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09900264 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07813315 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07348119 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07122277 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06624288 |
| 65 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05648333 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05281023 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04863443 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04432464 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03334550 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02907144 |
| 71 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02647619 |
| 72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02575379 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02175219 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01274013 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01138973 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00765032 |
| 77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98551766 |
| 78 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98416472 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98135222 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97724921 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96173492 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96067392 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94904801 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93775988 |
| 85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92469228 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91911114 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90739162 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89836546 |
| 89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89730202 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89009745 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88975635 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88727487 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88658604 |
| 94 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88494037 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88273096 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87634404 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87431602 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86192201 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85861044 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83913860 |
| 101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81846523 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81589650 |
| 103 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81462974 |
| 104 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80573413 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80175680 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.79563683 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79374181 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79201901 |
| 109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79045347 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78044791 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.73660146 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73591425 |
| 113 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.72259104 |
| 114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71428573 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71228920 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71010559 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70269012 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69137261 |
| 119 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.68400096 |
| 120 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.68025464 |
| 121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.68025464 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.66648369 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66140294 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66140294 |
| 125 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65922845 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.65877800 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65074422 |
| 128 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63134297 |
| 129 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62911437 |
| 130 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.61429009 |
| 131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61208235 |
| 132 | KDM2B_26808549_Chip-Seq_K562_Human | 0.61061006 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60630898 |
| 134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.60472499 |
| 135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60415925 |
| 136 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60396927 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59459362 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.58633495 |
| 139 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.57885284 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.57479417 |
| 141 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.57250891 |
| 142 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.56741262 |
| 143 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56535950 |
| 144 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55807095 |
| 145 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.55000203 |
| 146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54870139 |
| 147 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.54762957 |
| 148 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.54743624 |
| 149 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.54514111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.06953647 |
| 2 | MP0005360_urolithiasis | 6.55413280 |
| 3 | MP0005365_abnormal_bile_salt | 5.53695954 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.36738438 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.38494417 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 3.39854830 |
| 7 | MP0005083_abnormal_biliary_tract | 3.36127026 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.32005466 |
| 9 | MP0003252_abnormal_bile_duct | 3.29161358 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.14311703 |
| 11 | MP0009840_abnormal_foam_cell | 2.89233132 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.59561094 |
| 13 | MP0003195_calcinosis | 2.54636048 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.54533167 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.52484979 |
| 16 | MP0003011_delayed_dark_adaptation | 2.50279747 |
| 17 | MP0002254_reproductive_system_inflammat | 2.45500776 |
| 18 | MP0000566_synostosis | 2.39753471 |
| 19 | MP0005332_abnormal_amino_acid | 2.35371580 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 2.26712195 |
| 21 | MP0003878_abnormal_ear_physiology | 2.26712195 |
| 22 | MP0000751_myopathy | 2.25418405 |
| 23 | MP0005409_darkened_coat_color | 2.19690757 |
| 24 | MP0000609_abnormal_liver_physiology | 2.08468657 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.07582473 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.93095621 |
| 27 | MP0003879_abnormal_hair_cell | 1.91537886 |
| 28 | MP0004885_abnormal_endolymph | 1.86140860 |
| 29 | MP0004270_analgesia | 1.84769040 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.84325698 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.79365875 |
| 32 | MP0005670_abnormal_white_adipose | 1.76187959 |
| 33 | MP0002796_impaired_skin_barrier | 1.69628816 |
| 34 | MP0000467_abnormal_esophagus_morphology | 1.61206700 |
| 35 | MP0000749_muscle_degeneration | 1.59424007 |
| 36 | MP0005451_abnormal_body_composition | 1.57432202 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.56607336 |
| 38 | MP0003868_abnormal_feces_composition | 1.55262643 |
| 39 | MP0000762_abnormal_tongue_morphology | 1.48708657 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.43733722 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42743934 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.42446135 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.40378658 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.40135847 |
| 45 | MP0003941_abnormal_skin_development | 1.36801009 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.32727010 |
| 47 | MP0000747_muscle_weakness | 1.30682767 |
| 48 | MP0010771_integument_phenotype | 1.30423711 |
| 49 | MP0004381_abnormal_hair_follicle | 1.29132512 |
| 50 | MP0005330_cardiomyopathy | 1.27390904 |
| 51 | MP0004087_abnormal_muscle_fiber | 1.25435257 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.21364812 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.20891495 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.20724405 |
| 55 | MP0004859_abnormal_synaptic_plasticity | 1.20015947 |
| 56 | MP0005620_abnormal_muscle_contractility | 1.18859102 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.16495771 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.16244403 |
| 59 | MP0009764_decreased_sensitivity_to | 1.15569249 |
| 60 | MP0004272_abnormal_basement_membrane | 1.14050848 |
| 61 | MP0004130_abnormal_muscle_cell | 1.13796847 |
| 62 | MP0002971_abnormal_brown_adipose | 1.12576016 |
| 63 | MP0003045_fibrosis | 1.11705148 |
| 64 | MP0000604_amyloidosis | 1.11439375 |
| 65 | MP0008569_lethality_at_weaning | 1.10362267 |
| 66 | MP0002972_abnormal_cardiac_muscle | 1.09121225 |
| 67 | MP0003186_abnormal_redox_activity | 1.08495856 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.08157689 |
| 69 | MP0006138_congestive_heart_failure | 1.07010271 |
| 70 | MP0005248_abnormal_Harderian_gland | 1.06935232 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.05592090 |
| 72 | MP0009697_abnormal_copulation | 1.05383140 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.04803494 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.04607229 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.00067634 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.99507722 |
| 77 | MP0003690_abnormal_glial_cell | 0.97302784 |
| 78 | MP0001984_abnormal_olfaction | 0.96851053 |
| 79 | MP0002108_abnormal_muscle_morphology | 0.95951645 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.95595700 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.95515444 |
| 82 | MP0000598_abnormal_liver_morphology | 0.95179254 |
| 83 | MP0004484_altered_response_of | 0.93872735 |
| 84 | MP0001764_abnormal_homeostasis | 0.93481836 |
| 85 | MP0000579_abnormal_nail_morphology | 0.92800775 |
| 86 | MP0004858_abnormal_nervous_system | 0.91447100 |
| 87 | MP0009763_increased_sensitivity_to | 0.90045543 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.89249885 |
| 89 | MP0005423_abnormal_somatic_nervous | 0.88349741 |
| 90 | MP0005535_abnormal_body_temperature | 0.87664195 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.86717257 |
| 92 | MP0004043_abnormal_pH_regulation | 0.86670444 |
| 93 | MP0000462_abnormal_digestive_system | 0.86645530 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.86073905 |
| 95 | MP0000920_abnormal_myelination | 0.85644973 |
| 96 | MP0003329_amyloid_beta_deposits | 0.84722462 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 0.83387588 |
| 98 | MP0005408_hypopigmentation | 0.83369545 |
| 99 | MP0000759_abnormal_skeletal_muscle | 0.83115911 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.82688864 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.82562410 |
| 102 | MP0005334_abnormal_fat_pad | 0.80405562 |
| 103 | MP0005275_abnormal_skin_tensile | 0.79415649 |
| 104 | MP0002060_abnormal_skin_morphology | 0.78755723 |
| 105 | MP0005647_abnormal_sex_gland | 0.78387774 |
| 106 | MP0006082_CNS_inflammation | 0.77913720 |
| 107 | MP0008469_abnormal_protein_level | 0.77691279 |
| 108 | MP0010630_abnormal_cardiac_muscle | 0.77414374 |
| 109 | MP0005266_abnormal_metabolism | 0.77325884 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.76605635 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.76321211 |
| 112 | MP0004233_abnormal_muscle_weight | 0.75077807 |
| 113 | MP0001501_abnormal_sleep_pattern | 0.74833089 |
| 114 | MP0005448_abnormal_energy_balance | 0.74404819 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.73034825 |
| 116 | MP0004947_skin_inflammation | 0.72553951 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.72491548 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.71398089 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.70610736 |
| 120 | MP0010368_abnormal_lymphatic_system | 0.70529978 |
| 121 | MP0004085_abnormal_heartbeat | 0.69010948 |
| 122 | MP0003075_altered_response_to | 0.68133218 |
| 123 | MP0001664_abnormal_digestion | 0.68016353 |
| 124 | MP0003634_abnormal_glial_cell | 0.67389219 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.66878794 |
| 126 | MP0002734_abnormal_mechanical_nocicepti | 0.66117244 |
| 127 | MP0009115_abnormal_fat_cell | 0.65632056 |
| 128 | MP0005257_abnormal_intraocular_pressure | 0.65423780 |
| 129 | MP0000427_abnormal_hair_cycle | 0.65060245 |
| 130 | MP0002970_abnormal_white_adipose | 0.64898327 |
| 131 | MP0005369_muscle_phenotype | 0.64376528 |
| 132 | MP0001849_ear_inflammation | 0.64339064 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.64220954 |
| 134 | MP0009931_abnormal_skin_appearance | 0.64097640 |
| 135 | MP0005501_abnormal_skin_physiology | 0.64052940 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.63361362 |
| 137 | MP0000627_abnormal_mammary_gland | 0.62990259 |
| 138 | MP0002822_catalepsy | 0.62672591 |
| 139 | MP0000537_abnormal_urethra_morphology | 0.62566146 |
| 140 | MP0000647_abnormal_sebaceous_gland | 0.61780338 |
| 141 | MP0003183_abnormal_peptide_metabolism | 0.61708372 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.61078191 |
| 143 | MP0001756_abnormal_urination | 0.60342775 |
| 144 | MP0003436_decreased_susceptibility_to | 0.57405241 |
| 145 | MP0001216_abnormal_epidermal_layer | 0.57235152 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.56206180 |
| 147 | MP0002098_abnormal_vibrissa_morphology | 0.52798069 |
| 148 | MP0000383_abnormal_hair_follicle | 0.51434347 |
| 149 | MP0000377_abnormal_hair_follicle | 0.51123671 |
| 150 | MP0002269_muscular_atrophy | 0.50845516 |
| 151 | MP0010678_abnormal_skin_adnexa | 0.49683076 |
| 152 | MP0001324_abnormal_eye_pigmentation | 0.44536854 |
| 153 | MP0008874_decreased_physiological_sensi | 0.43691838 |
| 154 | MP0001243_abnormal_dermal_layer | 0.43536423 |
| 155 | MP0002136_abnormal_kidney_physiology | 0.43498923 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.42801786 |
| 157 | MP0003890_abnormal_embryonic-extraembry | 0.42405515 |
| 158 | MP0001661_extended_life_span | 0.42172949 |
| 159 | MP0002090_abnormal_vision | 0.40695116 |
| 160 | MP0005023_abnormal_wound_healing | 0.39768317 |
| 161 | MP0005220_abnormal_exocrine_pancreas | 0.39758547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.40648422 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.36343261 |
| 3 | Xanthomatosis (HP:0000991) | 6.19948958 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.94739382 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.49731024 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.28009894 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.86253094 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.84299896 |
| 9 | Complement deficiency (HP:0004431) | 4.81349168 |
| 10 | Epidermoid cyst (HP:0200040) | 4.71051092 |
| 11 | Abnormality of nail color (HP:0100643) | 4.52829542 |
| 12 | Hyperammonemia (HP:0001987) | 4.26995387 |
| 13 | Ketosis (HP:0001946) | 4.14579853 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 4.07862426 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.07393092 |
| 16 | Joint hemorrhage (HP:0005261) | 4.05791575 |
| 17 | Hyperglycinuria (HP:0003108) | 4.00866969 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.99144505 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.87166174 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84491796 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.84491796 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.81132992 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 3.80866765 |
| 24 | Exercise-induced myalgia (HP:0003738) | 3.79441363 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.79431697 |
| 26 | Hyperglycinemia (HP:0002154) | 3.79322098 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.79068353 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.72108450 |
| 29 | Onycholysis (HP:0001806) | 3.68665567 |
| 30 | Abnormality of complement system (HP:0005339) | 3.67435202 |
| 31 | Skin nodule (HP:0200036) | 3.65025972 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.61977176 |
| 33 | Fat malabsorption (HP:0002630) | 3.60639596 |
| 34 | Plantar hyperkeratosis (HP:0007556) | 3.52689179 |
| 35 | Palmoplantar hyperkeratosis (HP:0000972) | 3.49418087 |
| 36 | Ketoacidosis (HP:0001993) | 3.41264664 |
| 37 | Hyperkalemia (HP:0002153) | 3.39267953 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.37086324 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.35425309 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 3.33099712 |
| 41 | Muscle fiber splitting (HP:0003555) | 3.28176175 |
| 42 | Palmar hyperkeratosis (HP:0010765) | 3.21118191 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.15149109 |
| 44 | Bundle branch block (HP:0011710) | 3.09845846 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 3.09681155 |
| 46 | Myocardial infarction (HP:0001658) | 3.09274251 |
| 47 | Ventricular tachycardia (HP:0004756) | 3.05201168 |
| 48 | Sudden death (HP:0001699) | 3.04936987 |
| 49 | Hypotrichosis (HP:0001006) | 3.03502825 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 3.02591687 |
| 51 | Pili torti (HP:0003777) | 2.95348446 |
| 52 | Abnormality of secondary sexual hair (HP:0009888) | 2.92536777 |
| 53 | Abnormality of the axillary hair (HP:0100134) | 2.92536777 |
| 54 | Abnormality of the salivary glands (HP:0010286) | 2.89657458 |
| 55 | Alopecia of scalp (HP:0002293) | 2.88374007 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.87121277 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86983418 |
| 58 | Milia (HP:0001056) | 2.82629973 |
| 59 | Muscle fiber inclusion bodies (HP:0100299) | 2.82498438 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.78983856 |
| 61 | Amyloidosis (HP:0011034) | 2.78253349 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.72130053 |
| 63 | Nemaline bodies (HP:0003798) | 2.71527569 |
| 64 | Steatorrhea (HP:0002570) | 2.71034114 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.69812186 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.68483436 |
| 67 | Corneal erosion (HP:0200020) | 2.68089121 |
| 68 | Type 1 muscle fiber predominance (HP:0003803) | 2.63563175 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.63467838 |
| 70 | Malnutrition (HP:0004395) | 2.62541108 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.62018985 |
| 72 | Exercise-induced muscle cramps (HP:0003710) | 2.58924904 |
| 73 | Woolly hair (HP:0002224) | 2.55396260 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.54618946 |
| 75 | Increased IgE level (HP:0003212) | 2.53915464 |
| 76 | Lip pit (HP:0100267) | 2.53854381 |
| 77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53436642 |
| 78 | Gout (HP:0001997) | 2.52903630 |
| 79 | Abnormal cartilage morphology (HP:0002763) | 2.51622308 |
| 80 | Metabolic acidosis (HP:0001942) | 2.51480076 |
| 81 | Syncope (HP:0001279) | 2.51002395 |
| 82 | Cholelithiasis (HP:0001081) | 2.49997035 |
| 83 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.49996186 |
| 84 | Aplasia of the phalanges of the hand (HP:0009802) | 2.49996186 |
| 85 | Aplasia involving bones of the extremities (HP:0009825) | 2.49996186 |
| 86 | Abnormality of the lower motor neuron (HP:0002366) | 2.49459509 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.49199286 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49199286 |
| 89 | Hyperactive renin-angiotensin system (HP:0000841) | 2.48299372 |
| 90 | Abnormality of the Achilles tendon (HP:0005109) | 2.47052644 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 2.45729549 |
| 92 | Fragile nails (HP:0001808) | 2.41552482 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.40642335 |
| 94 | Thick nail (HP:0001805) | 2.40584952 |
| 95 | EMG: myopathic abnormalities (HP:0003458) | 2.38212632 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.38133910 |
| 97 | Erythema (HP:0010783) | 2.37986382 |
| 98 | Abnormal hair laboratory examination (HP:0003328) | 2.31027975 |
| 99 | Abnormality of the calf musculature (HP:0001430) | 2.30957658 |
| 100 | Right ventricular cardiomyopathy (HP:0011663) | 2.30025831 |
| 101 | Spastic diplegia (HP:0001264) | 2.29343936 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29271149 |
| 103 | Neurofibrillary tangles (HP:0002185) | 2.29127635 |
| 104 | Increased connective tissue (HP:0009025) | 2.28113578 |
| 105 | Abnormality of serum amino acid levels (HP:0003112) | 2.28105998 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.27265540 |
| 107 | Cholecystitis (HP:0001082) | 2.26661430 |
| 108 | Abnormal gallbladder physiology (HP:0012438) | 2.26661430 |
| 109 | Palmoplantar keratoderma (HP:0000982) | 2.26511429 |
| 110 | Abnormality of permanent molar morphology (HP:0011071) | 2.25975127 |
| 111 | Abnormality of the dental root (HP:0006486) | 2.25975127 |
| 112 | Taurodontia (HP:0000679) | 2.25975127 |
| 113 | Glomerulonephritis (HP:0000099) | 2.25589489 |
| 114 | Alacrima (HP:0000522) | 2.24583161 |
| 115 | Hemorrhage of the eye (HP:0011885) | 2.24056050 |
| 116 | Ventricular fibrillation (HP:0001663) | 2.22483677 |
| 117 | Difficulty running (HP:0009046) | 2.20944568 |
| 118 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.19915685 |
| 119 | Advanced eruption of teeth (HP:0006288) | 2.19631371 |
| 120 | Irritability (HP:0000737) | 2.19202755 |
| 121 | Esophageal varix (HP:0002040) | 2.18220132 |
| 122 | Ankle clonus (HP:0011448) | 2.17708726 |
| 123 | Vascular calcification (HP:0004934) | 2.17179682 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 2.16051297 |
| 125 | Myopathic facies (HP:0002058) | 2.14340695 |
| 126 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.13529552 |
| 127 | Abnormal atrioventricular conduction (HP:0005150) | 2.13468831 |
| 128 | Calf muscle hypertrophy (HP:0008981) | 2.11963780 |
| 129 | Heart block (HP:0012722) | 2.11618432 |
| 130 | Mitral stenosis (HP:0001718) | 2.09990850 |
| 131 | Abnormality of molar morphology (HP:0011070) | 2.09422331 |
| 132 | Abnormality of molar (HP:0011077) | 2.09422331 |
| 133 | Tetraplegia (HP:0002445) | 2.05094038 |
| 134 | Neonatal onset (HP:0003623) | 2.04274837 |
| 135 | Hepatoblastoma (HP:0002884) | 2.04223517 |
| 136 | Conjunctival hamartoma (HP:0100780) | 2.03559688 |
| 137 | Ventricular arrhythmia (HP:0004308) | 2.03516271 |
| 138 | Pancreatitis (HP:0001733) | 2.03469731 |
| 139 | EMG: neuropathic changes (HP:0003445) | 2.02123869 |
| 140 | Myoglobinuria (HP:0002913) | 2.01721523 |
| 141 | Lethargy (HP:0001254) | 2.01018286 |
| 142 | Multiple enchondromatosis (HP:0005701) | 1.97497513 |
| 143 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96979289 |
| 144 | Neoplasm of the heart (HP:0100544) | 1.96963298 |
| 145 | Abnormality of the dental pulp (HP:0006479) | 1.96919370 |
| 146 | Bronchomalacia (HP:0002780) | 1.96836648 |
| 147 | Status epilepticus (HP:0002133) | 1.96558646 |
| 148 | Laryngomalacia (HP:0001601) | 1.95835505 |
| 149 | Hypoplasia of dental enamel (HP:0006297) | 1.95110733 |
| 150 | Foot dorsiflexor weakness (HP:0009027) | 1.94556181 |
| 151 | Popliteal pterygium (HP:0009756) | 1.92950536 |
| 152 | Abnormality of the gallbladder (HP:0005264) | 1.92512552 |
| 153 | Cardiovascular calcification (HP:0011915) | 1.92260063 |
| 154 | Upper motor neuron abnormality (HP:0002127) | 1.91918976 |
| 155 | Neck muscle weakness (HP:0000467) | 1.91333899 |
| 156 | Atrophic scars (HP:0001075) | 1.91321221 |
| 157 | Gingival bleeding (HP:0000225) | 1.90724100 |
| 158 | Hyperglycemia (HP:0003074) | 1.90516753 |
| 159 | Dysmetric saccades (HP:0000641) | 1.89811548 |
| 160 | Abnormal blistering of the skin (HP:0008066) | 1.87821428 |
| 161 | Polar cataract (HP:0010696) | 1.87808792 |
| 162 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87749795 |
| 163 | Nail dystrophy (HP:0008404) | 1.87686800 |
| 164 | Achilles tendon contracture (HP:0001771) | 1.87149803 |
| 165 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.87074580 |
| 166 | Pseudobulbar signs (HP:0002200) | 1.86766247 |
| 167 | Vomiting (HP:0002013) | 1.86383656 |
| 168 | Late onset (HP:0003584) | 1.85887993 |
| 169 | Decreased lacrimation (HP:0000633) | 1.84931272 |
| 170 | Peritonitis (HP:0002586) | 1.84344446 |
| 171 | Menorrhagia (HP:0000132) | 1.83740880 |
| 172 | Atrioventricular block (HP:0001678) | 1.83367021 |
| 173 | Abnormality of proline metabolism (HP:0010907) | 1.82911679 |
| 174 | Hydroxyprolinuria (HP:0003080) | 1.82911679 |
| 175 | Spontaneous abortion (HP:0005268) | 1.81701461 |
| 176 | Abnormality of the foot musculature (HP:0001436) | 1.80433106 |
| 177 | Acanthocytosis (HP:0001927) | 1.79417731 |
| 178 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79397869 |
| 179 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78001550 |
| 180 | Nephritis (HP:0000123) | 1.77202075 |
| 181 | Rickets (HP:0002748) | 1.76725732 |
| 182 | Sensorimotor neuropathy (HP:0007141) | 1.76638304 |
| 183 | Abnormality of iron homeostasis (HP:0011031) | 1.76442627 |
| 184 | Hamartoma of the eye (HP:0010568) | 1.75738831 |
| 185 | Ragged-red muscle fibers (HP:0003200) | 1.75690534 |
| 186 | Ridged nail (HP:0001807) | 1.75249727 |
| 187 | Abnormality of sodium homeostasis (HP:0010931) | 1.74793411 |
| 188 | Rhabdomyolysis (HP:0003201) | 1.71528499 |
| 189 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70244960 |
| 190 | Acanthosis nigricans (HP:0000956) | 1.69377470 |
| 191 | Erythroderma (HP:0001019) | 1.69043374 |
| 192 | Scapular winging (HP:0003691) | 1.66131025 |
| 193 | Stridor (HP:0010307) | 1.65770408 |
| 194 | Myokymia (HP:0002411) | 1.64713599 |
| 195 | Aortic aneurysm (HP:0004942) | 1.64418012 |
| 196 | Hyperparathyroidism (HP:0000843) | 1.63495689 |
| 197 | Subaortic stenosis (HP:0001682) | 1.62950770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.55500095 |
| 2 | BCKDK | 3.85217484 |
| 3 | MST1R | 3.33059588 |
| 4 | SIK1 | 3.25934511 |
| 5 | CDK12 | 2.99391330 |
| 6 | FGFR4 | 2.72463885 |
| 7 | GRK5 | 2.63189387 |
| 8 | PRKD3 | 2.39353095 |
| 9 | GRK6 | 2.34367655 |
| 10 | INSRR | 2.34206405 |
| 11 | TRIB3 | 2.31887146 |
| 12 | PHKG1 | 2.29908566 |
| 13 | PHKG2 | 2.29908566 |
| 14 | LMTK2 | 2.25487897 |
| 15 | EEF2K | 2.25448113 |
| 16 | RIPK1 | 2.19048112 |
| 17 | MYLK | 2.15122292 |
| 18 | MAP2K4 | 1.98906507 |
| 19 | TGFBR2 | 1.77530117 |
| 20 | GRK1 | 1.75606002 |
| 21 | DMPK | 1.66726494 |
| 22 | LATS1 | 1.63559668 |
| 23 | TAOK3 | 1.58271248 |
| 24 | TRPM7 | 1.50736081 |
| 25 | PIK3CG | 1.47958306 |
| 26 | PTK6 | 1.45398741 |
| 27 | PKN2 | 1.39969707 |
| 28 | MET | 1.38291249 |
| 29 | FGFR3 | 1.37231192 |
| 30 | TYK2 | 1.30025113 |
| 31 | CSF1R | 1.28587402 |
| 32 | MATK | 1.27481693 |
| 33 | TESK1 | 1.26679507 |
| 34 | CAMK1D | 1.25868563 |
| 35 | CSK | 1.18525807 |
| 36 | SGK223 | 1.15675226 |
| 37 | SGK494 | 1.15675226 |
| 38 | MAP3K7 | 1.12201700 |
| 39 | ERBB4 | 1.11858354 |
| 40 | FGFR2 | 1.11667466 |
| 41 | TYRO3 | 1.11328360 |
| 42 | ADRBK2 | 1.10176798 |
| 43 | JAK1 | 1.08547853 |
| 44 | NEK6 | 1.08457861 |
| 45 | EPHA4 | 1.06651988 |
| 46 | MAPK7 | 1.06506763 |
| 47 | DAPK2 | 1.05928388 |
| 48 | NTRK1 | 1.04930195 |
| 49 | GRK7 | 1.04923548 |
| 50 | BMX | 1.03584218 |
| 51 | MAPK11 | 1.02497253 |
| 52 | JAK2 | 1.02406842 |
| 53 | EPHB1 | 1.02396652 |
| 54 | NTRK3 | 0.98789550 |
| 55 | SGK2 | 0.97273133 |
| 56 | FRK | 0.96684887 |
| 57 | WNK1 | 0.96640060 |
| 58 | MARK1 | 0.95912319 |
| 59 | UHMK1 | 0.95714818 |
| 60 | PRKAA2 | 0.94649734 |
| 61 | CAMK2G | 0.92737208 |
| 62 | MAPK12 | 0.91980770 |
| 63 | ARAF | 0.91901250 |
| 64 | CAMK4 | 0.89798145 |
| 65 | MOS | 0.88656616 |
| 66 | MAPKAPK3 | 0.88003734 |
| 67 | PDK2 | 0.85966847 |
| 68 | MAP3K10 | 0.85652500 |
| 69 | ERBB2 | 0.85551923 |
| 70 | STK10 | 0.85466336 |
| 71 | STK39 | 0.84676150 |
| 72 | CAMK2B | 0.82948864 |
| 73 | ROCK1 | 0.81652665 |
| 74 | PTK2 | 0.80901513 |
| 75 | PRKD2 | 0.80752091 |
| 76 | PRPF4B | 0.78625219 |
| 77 | KSR2 | 0.78493689 |
| 78 | MAP2K6 | 0.78261346 |
| 79 | PIK3CA | 0.77744101 |
| 80 | RPS6KA2 | 0.76882226 |
| 81 | FLT3 | 0.74527080 |
| 82 | STK24 | 0.73511553 |
| 83 | TAOK1 | 0.72645520 |
| 84 | FER | 0.70438669 |
| 85 | TIE1 | 0.70094922 |
| 86 | MAP3K3 | 0.69824310 |
| 87 | PRKG2 | 0.68473542 |
| 88 | PRKAA1 | 0.68402795 |
| 89 | ROCK2 | 0.67118216 |
| 90 | MAPKAPK5 | 0.66866591 |
| 91 | CDC42BPA | 0.66808976 |
| 92 | CAMK1G | 0.66268328 |
| 93 | PDGFRA | 0.65458564 |
| 94 | TNK2 | 0.64866859 |
| 95 | DDR2 | 0.64113589 |
| 96 | CAMK1 | 0.63936229 |
| 97 | MAP3K1 | 0.62428201 |
| 98 | GSK3A | 0.62187839 |
| 99 | EPHA2 | 0.62132746 |
| 100 | TBK1 | 0.61847385 |
| 101 | MAP2K1 | 0.61744874 |
| 102 | PINK1 | 0.61054628 |
| 103 | TTN | 0.60930508 |
| 104 | MAP3K12 | 0.60882967 |
| 105 | PRKACG | 0.60097574 |
| 106 | MAP3K2 | 0.57748069 |
| 107 | EPHA3 | 0.56872945 |
| 108 | MTOR | 0.56378813 |
| 109 | ABL2 | 0.54743362 |
| 110 | PAK6 | 0.54044039 |
| 111 | ADRBK1 | 0.53461073 |
| 112 | NEK9 | 0.53346782 |
| 113 | IGF1R | 0.52356792 |
| 114 | CAMK2D | 0.52350137 |
| 115 | SGK1 | 0.50976321 |
| 116 | ILK | 0.50273135 |
| 117 | AKT2 | 0.49396938 |
| 118 | MAP3K13 | 0.49216778 |
| 119 | PRKCH | 0.48984370 |
| 120 | CDK5 | 0.48560375 |
| 121 | ITK | 0.48066642 |
| 122 | MARK2 | 0.47820296 |
| 123 | PRKCZ | 0.47742918 |
| 124 | MAPK4 | 0.47645609 |
| 125 | RET | 0.46848434 |
| 126 | MAP3K9 | 0.46740997 |
| 127 | MAPK15 | 0.46387402 |
| 128 | MAPK10 | 0.46280397 |
| 129 | STK38 | 0.44779818 |
| 130 | STK38L | 0.43420017 |
| 131 | AKT3 | 0.43022327 |
| 132 | MAP2K3 | 0.42630390 |
| 133 | IRAK3 | 0.41896890 |
| 134 | DYRK1B | 0.39706730 |
| 135 | PDPK1 | 0.39401621 |
| 136 | HIPK2 | 0.39118217 |
| 137 | MAP3K14 | 0.38617342 |
| 138 | PRKD1 | 0.38521660 |
| 139 | PAK3 | 0.36957547 |
| 140 | LATS2 | 0.36697556 |
| 141 | SGK3 | 0.34748909 |
| 142 | PDK1 | 0.34520643 |
| 143 | CAMKK1 | 0.33791355 |
| 144 | FGFR1 | 0.30739271 |
| 145 | EPHB2 | 0.29500757 |
| 146 | MAP3K6 | 0.29017597 |
| 147 | ICK | 0.28643714 |
| 148 | OBSCN | 0.28112484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08154339 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66656095 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05088282 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.91181270 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90635941 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60245714 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58421478 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52685632 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51603158 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32772587 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27717148 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.20125992 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17542530 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12676080 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00029669 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99512844 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92779623 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92477120 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.90705852 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.89957626 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87152461 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86809422 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84659878 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76832498 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.66967126 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63949470 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.63607265 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63568440 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.62972993 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61074153 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.57432697 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56769845 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.55856981 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51451463 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45034057 |
| 36 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.44758065 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43186148 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41733916 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39312148 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36969408 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.36238745 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33441190 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33071597 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32103804 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28325203 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.27895272 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27533312 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.24127773 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23009671 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20851517 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20738990 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18990979 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 1.17720827 |
| 54 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15163146 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14766138 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14764361 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11702670 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 1.07872151 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06686601 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04504250 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 1.03949195 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02498238 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00255821 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00192395 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99722008 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98756748 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98399189 |
| 68 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98100264 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96803349 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96402860 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93857088 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92505211 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92070299 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91557310 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.91279837 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90822514 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90519270 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88668908 |
| 79 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88066765 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86692774 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85181839 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85158139 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.83976628 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83941981 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83503761 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82522369 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82480232 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81313599 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78661736 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78563067 |
| 91 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77709824 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77189020 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75986213 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73979750 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73687940 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73245583 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69319202 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.69110149 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68802104 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68498850 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67226025 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.61387915 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59385555 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58825376 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58524241 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58217841 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58041785 |
| 108 | Melanogenesis_Homo sapiens_hsa04916 | 0.57834701 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57262242 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56974841 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56346353 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55949081 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55519150 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.54863106 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54327128 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54149822 |
| 117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54039259 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53764992 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.51616194 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47576318 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45527151 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38134280 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37851165 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34338421 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.34036842 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33247452 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25450974 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22897352 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21878423 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17878420 |
| 131 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.15652637 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12905142 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12499789 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08858648 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.04762111 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04627697 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03249975 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.02819536 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.02255110 |
| 140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01602638 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.01327002 |
| 142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00681658 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0731617 |
| 144 | Lysosome_Homo sapiens_hsa04142 | -0.0590588 |
| 145 | Pertussis_Homo sapiens_hsa05133 | -0.0553672 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0294246 |
| 147 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0169689 |
| 148 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0157385 |
| 149 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0131577 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | -0.0013892 |

